Show notes
This week, we dissect the major regulatory shift in Singapore, as the Health Sciences Authority (HSA) releases groundbreaking new guidance for AI and Machine Learning medical devices. This move tightens the rules on "continuous learning" algorithms and sets a potential new global standard for the industry.
This update places a heavy new burden on manufacturers, requiring detailed pre-planned modification protocols and intensive post-market surveillance. We explore what this means for innovators and why simply launching your product is no longer enough.
Case Study Spotlight: Imagine your AI…
Website: pureglobal.com
